Compare HBIO & COSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HBIO | COSM |
|---|---|---|
| Founded | 1901 | 2009 |
| Country | United States | Greece |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Other Pharmaceuticals |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 26.5M | 27.9M |
| IPO Year | 2000 | 2009 |
| Metric | HBIO | COSM |
|---|---|---|
| Price | $8.13 | $0.38 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 14.8K | ★ 3.4M |
| Earning Date | 11-05-2026 | 11-16-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 46.15 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $116,176,000.00 | $65,271,815.00 |
| Revenue This Year | $3.76 | $23.79 |
| Revenue Next Year | $5.29 | $37.13 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 19.93 |
| 52 Week Low | $0.38 | $0.16 |
| 52 Week High | $8.40 | $1.32 |
| Indicator | HBIO | COSM |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 68.08 |
| Support Level | N/A | $0.27 |
| Resistance Level | N/A | $0.48 |
| Average True Range (ATR) | 0.00 | 0.04 |
| MACD | 0.00 | 0.01 |
| Stochastic Oscillator | 0.00 | 72.90 |
Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, products, and services that enable advances in life science applications, including research, drug and therapy discovery, bioproduction, and preclinical testing. The company organizes its product line into two product families: Cellular and Molecular Technologies (CMT) and Preclinical. The CMT product family supports molecular, cellular, organ, and organoid research, as well as bioproduction and in vitro testing, while the Preclinical product family provides products for preclinical research and testing, including data collection and analysis for safety and regulatory compliance. Its geographical segments include the Americas, Europe, Middle East and Africa, and Asia.
Cosmos Health Inc is a diversified, vertically integrated healthcare group, owner of proprietary pharmaceutical and nutraceutical brands, generics, manufacturer and distributor of healthcare products, engaged in research & development of medicines and repurposing drugs as well as operator of a telehealth platform. The company has developed its own proprietary branded nutraceutical products, named 'Sky Premium Life' and 'Mediterranation'. Its product portfolio includes generics and over-the-counter pharmaceutical products, medicines, as well as nutraceuticals and biocides. The company's Reportable segments are Wholesale, Pharma manufacturing, and Nutraceutical and pharmaceuticals, with the majority of revenue generated from the Wholesale segment.